Transcription of 1094 CAPSULES DISSOLUTION TESTING AND RELATED …
{{id}} {{{paragraph}}}
Printed on: Fri May 14 2021, 10:24:13 AM Official Status: Currently Official on 14-May-2021 DocId: 1_GUID-794D7F65-D715-4719-9A14-5C80B55C5 FC9_2_en-US. (EST). Printed by: Deborah Nishikawa Official Date: Official as of 01-Dec-2020 Document Type: GENERAL CHAPTER @2021 USPC. 1. 1094 CAPSULES DISSOLUTION TESTING AND RELATED QUALITY. ATTRIBUTES. 1. INTRODUCTION. This general information chapter provides approaches for the development of DISSOLUTION test procedures for CAPSULES , which are not provided by DISSOLUTION 711 , Drug Release 724 , The DISSOLUTION Procedure: Development and Validation 1092 , and Disintegration and DISSOLUTION of Dietary Supplements 2040.
The covalent bonding produced with this type of cross-linking is, for all practical purposes, irreversible, and dissolution of the shell must involve the breaking of other bonds such as the enzyme-mediated breaking of the peptide bonds in the protein chains.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}